0001104659-19-042699.txt : 20190730
0001104659-19-042699.hdr.sgml : 20190730
20190730192243
ACCESSION NUMBER: 0001104659-19-042699
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190726
FILED AS OF DATE: 20190730
DATE AS OF CHANGE: 20190730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: van der Velden Peter
CENTRAL INDEX KEY: 0001778046
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37619
FILM NUMBER: 19986908
MAIL ADDRESS:
STREET 1: C/O EDESA BIOTECH INC.
STREET 2: 100 SPY COURT
CITY: MARKHAM
STATE: A6
ZIP: L3R 5H6
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lumira Capital Investment Management Inc.
CENTRAL INDEX KEY: 0001702636
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37619
FILM NUMBER: 19986909
BUSINESS ADDRESS:
STREET 1: 141 ADELAIDE STREET WEST
STREET 2: SUITE 770
CITY: TORONTO
STATE: A6
ZIP: M5H 3L5
BUSINESS PHONE: 416-213-4223
MAIL ADDRESS:
STREET 1: 141 ADELAIDE STREET WEST
STREET 2: SUITE 770
CITY: TORONTO
STATE: A6
ZIP: M5H 3L5
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edesa Biotech, Inc.
CENTRAL INDEX KEY: 0001540159
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 100 SPY COURT
CITY: MARKHAM
STATE: A6
ZIP: L3R 5H6
BUSINESS PHONE: (905) 475-1234
MAIL ADDRESS:
STREET 1: 100 SPY COURT
CITY: MARKHAM
STATE: A6
ZIP: L3R 5H6
FORMER COMPANY:
FORMER CONFORMED NAME: Stellar Biotechnologies, Inc.
DATE OF NAME CHANGE: 20120120
4
1
a4.xml
4
X0306
4
2019-07-26
0
0001540159
Edesa Biotech, Inc.
EDSA
0001778046
van der Velden Peter
C/O EDESA BIOTECH, INC. 100 SPY COURT
MARKHAM
A6
L3R 5H6
ONTARIO, CANADA
1
0
1
0
0001702636
Lumira Capital Investment Management Inc.
C/O EDESA BIOTECH, INC. 100 SPY COURT
MARKHAM
A6
L3R 5H6
ONTARIO, CANADA
0
0
1
0
Common Shares
2019-07-26
4
A
0
93006
0.00
A
1704344
I
Held by Lumira Capital II, L.P.
Common Shares
2019-07-26
4
A
0
8600
0.00
A
157599
I
Held by Lumira Capital II (International), L.P.
Represents additional common shares of Edesa Biotech, Inc. (formerly known as Stellar Biotechnologies, Inc.) (the "Issuer") issued pursuant to the post-closing adjustment contemplated by that certain Share Exchange Agreement, dated as of March 7, 2019, by and among the Issuer, Edesa Biotech, Inc. ("Edesa"), and the shareholders of Edesa. The closing of the share exchange transaction contemplated by the Share Exchange Agreement occurred on June 7, 2019, at which time the Issuer acquired all the outstanding capital shares of Edesa from the Edesa shareholders.
All share numbers reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019.
This Form 4 is jointly filed by (i) Lumira Capital II, L.P. ("LCII LP"), (ii) Lumira Capital II (International), L.P. ("LCII INT LP"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc., (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P., the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any.
/s/ Peter van der Velden
2019-07-30
LUMIRA CAPITAL INVESTMENT MANAGEMENT INC. By: /s/ Vasco Larcina Name: Vasco Larcina Title: VP Finance
2019-07-30